Latest @ Ipca

Ipca - Ratlam formulations plant ranked third position in the National Energy Conservation Award - 2010.



  • February -
    Ipca Dehradun won the 'Energy Conservation' Award for the 3rd year in a row.
    March -
    At the meeting of the Board of Directors of the Company held on 23rd March 2013, Dr. Ramakant Panda was appointed as Additional Director of the Company.
    April -
    Clinical study, 'Comparative Evaluation of efficacy and safety of Artesunate -Lumefantrine fixed dose combination in the treatment of uncomplicated Plasmodium Falciparum malaria' was published in the journal, 'Tropical Medicine and International Health', Europe.
    June -
    Clinical study, 'Comparison of gastro-intestinal safety and tolerability of Aceclofenac with Diclofenac: a multicenter, randomized, double-blind study in patients with knee osteo-arthritis'was published in the journal, 'Current Medical Research and Opinion', London, United Kingdom. This was the largest study conducted till date by Ipca.
    Ipca's API Plant at Indore was awarded the 'Environmental Award' for the fiscal year 2011-2012 by the Industry Minister of Madhya Pradesh, Mr. Kailash Vijayvargiya, for taking preventive measures to control pollution.
    July -
    Ipca featured on the 8th position in the list of 'India's Most Admired Companies', in a survey carried out by Fortune India, in collaboration with The Hay Group, for the second time.
    September -
    Ipca's Albendazole brand, Nemozole makes it to the No. 1 position in the Russian market by capturing 40% of market share among the anthelmintics' brands and growth propelling at the rate of 36%.
    October -
    Ipca received 'Corporate Citizen Award' for best corporate governance practice. Citi Commercial Bank a division of Citibank, N.A., India in partnership with CNBC TV 18 organized 'Thought Leadership Conclave 2013' in Mumbai.
Copyright © Ipca Laboratories Ltd. 2012. All Rights Reserved.